DUBLIN, Ireland--(BUSINESS WIRE)--FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TA KEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

1. KEY INFORMATION

Name of person dealing (Note 1)			Covidien plc
Company dealt in			Covidien plc
Class of relevant security to which the dealings being disclosed relate (Note 2)			Ordinary Shares
Date of dealing			1 July 2014

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

			Long					Short
			Number		(%)			Number		(%)
(1) Relevant securities			N/A – Covidien plc only holds treasury shares
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:			Long					Short
			Number		(%)			Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale			Number of relevant securities			Price per unit (Note 5)
Purchase (Redemption to Treasury)			31,169			US$90.86

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD			Nature of transaction (Note 6)			Number of relevant securities (Note 7)			Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option			Number of securities			Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)			Details			Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure			2 July 2014
Contact name			Lisa Clemence
Telephone number			+1 508-452-4375
Name of offeree/offeror with which acting in concert			Covidien plc
Specify category and nature of acting in concert status			Director of Covidien plc

A person interested in 1% or more of any relevant securities in the Covidien plc (the “Company”) may have disclosure obligations under Rule 8.3 of the Irish Takeover Rules. This requirement will continue until the offer period ends.

The directors of the Company accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the directors (who have taken all reasonable care to ensure that such is the case) the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

< iv="">< div="">

Contacts

Covidien
Peter Lucht, 508-452-4168
Vice President
External Communications
peter.lucht@covidien.com
or
Lisa Clemence, 508-452-4375
Director
Corporate Communications
lisa.clemence@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Todd Carpenter, 508-452-4363
Senior Director
Investor Relations
todd.carpenter@covidien.com